Award recordCONTRACT

EXACT SCIENCES CORPORATION

PIID 36C26122N0120· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· Q301 · REFERENCE LABORATORY TESTING· FY2022· $236,887 net obligations· UEI NGBXEJX5GLE9· WI

Description

GENOMIC ONCOTYPE DX LAB TESTING - OY3, MODIFY CONTRACT

Base award description: GENOMIC ONCOTYPE DX LAB TESTING

First action · last action
2021-10-01 · 2025-10-01
Transactions
11
First transaction's obligation
$234,744
Base + all options value (sum of deltas)
$435,252
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70053
NAICS
621511 · MEDICAL LABORATORIES

Modification chain · 11 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$373,700$0Base award · 2021-10-01 · this action $234,744 · running total $234,744Modification P00001 · 2022-06-01 · this action -$95,788 · running total $138,956Modification P00002 · 2022-10-03 · this action $234,744 · running total $373,700Modification P00004 · 2022-10-03 · this action $0 · running total $373,700Modification P00005 · 2023-09-24 · this action -$48,510 · running total $325,190Modification P00007 · 2023-10-01 · this action $36,378 · running total $361,568Modification P00008 · 2024-02-18 · this action -$205,224 · running total $156,344Modification P00010 · 2024-08-29 · this action $1,697 · running total $158,040Modification P00009 · 2024-10-01 · this action $44,645 · running total $202,685Modification P00011 · 2025-04-07 · this action -$10,443 · running total $192,242Modification P00012 · 2025-10-01 · this action $44,645 · running total $236,887
  • Base2021-10-01+$234,744= $234,744
  • Mod P000012022-06-01-$95,788= $138,956
  • Mod P000022022-10-03+$234,744= $373,700
  • Mod P000042022-10-03+$0= $373,700
  • Mod P000052023-09-24-$48,510= $325,190
  • Mod P000072023-10-01+$36,378= $361,568
  • Mod P000082024-02-18-$205,224= $156,344
  • Mod P000102024-08-29+$1,697= $158,040
  • Mod P000092024-10-01+$44,645= $202,685
  • Mod P000112025-04-07-$10,443= $192,242
  • Mod P000122025-10-01+$44,645= $236,887
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-10-01+$234,744$234,744GENOMIC ONCOTYPE DX LAB TESTING
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-06-01−$95,788$138,956GENOMIC ONCOTYPE DX LAB TESTING
Mod P00002· EXERCISE AN OPTION2022-10-03+$234,744$373,700GENOMIC ONCOTYPE DX LAB TESTING EXERCISING -9 OPTION TO EXTEND TERM OF THE CONTRACT
Mod P00004· OTHER ADMINISTRATIVE ACTION2022-10-03+$0$373,700GENOMIC ONCOTYPE DX LAB TESTING MOD TO CORRECT TYPOGRAPHICAL ERROR
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-09-24−$48,510$325,190GENOMIC ONCOTYPE DX LAB TESTING - DEOB FY 23 FUNDING
Mod P00007· EXERCISE AN OPTION2023-10-01+$36,378$361,568GENOMIC ONCOTYPE DX LAB TESTING - DEOB FY 23 FUNDING
Mod P00008· FUNDING ONLY ACTION2024-02-18−$205,224$156,344GENOMIC ONCOTYPE DX LAB TESTING - DEOB FY 23 FUNDING
Mod P00010· OTHER ADMINISTRATIVE ACTION2024-08-29+$1,697$158,040GENOMIC ONCOTYPE DX LAB TESTING - INCREASE FY 24 FUNDING
Mod P00009· EXERCISE AN OPTION2024-10-01+$44,645$202,685GENOMIC ONCOTYPE DX LAB TESTING - OY3, MODIFY CONTRACT
Mod P00011· FUNDING ONLY ACTION2025-04-07−$10,443$192,242GENOMIC ONCOTYPE DX LAB TESTING - OY3, MODIFY CONTRACT
Mod P00012· OTHER ADMINISTRATIVE ACTION2025-10-01+$44,645$236,887GENOMIC ONCOTYPE DX LAB TESTING - OY3, MODIFY CONTRACT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NGBXEJX5GLE9)

AwardOffice · PSC / listingNet obligationsFY
36C25726N0419257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING$127,174FY2026
36C25726N0252257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING$52,215FY2026
36C25526N0057255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING$3,454FY2026
36C25526N0054255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING$24,259FY2026
36C25526N0056255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING$3,454FY2026
36C25526N0055255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING$3,116FY2026

Other recipients under Q301 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P0942PACIFIC BIOLABS INC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,304FY2026
36C26126P0937MAYO COLLABORATIVE SERVICES, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$682FY2026
36C26126N0502CYTOPATH BIOPSY LAB INC261-NETWORK CONTRACT OFFICE 21 (36C261)$72,000FY2026
36C26126N0382QUEST DIAGNOSTICS INCORPORATED261-NETWORK CONTRACT OFFICE 21 (36C261)$611,688FY2026
36C26126N0436LABORATORY CORPORATION OF AMERICA261-NETWORK CONTRACT OFFICE 21 (36C261)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26122N0120_3600_V797D70053_3600 · retrieved 2026-09-26.